Overview

A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

Status:
NOT_YET_RECRUITING

Trial end date:
2026-04-27

Target enrollment:

Participant gender:

Summary

This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.

Phase:

PHASE1

Details

Lead Sponsor:

Sanofi

Treatments:

Moxifloxacin